Page last updated: 2024-08-26

arsenic and vitamin d 2

arsenic has been researched along with vitamin d 2 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Byrn, SR	1
Desmond, JC; Hewison, M; Hughes, SV; Koeffler, HP; Kumagai, T; O'Kelly, J; Shih, LY	1

Reviews

1 review(s) available for arsenic and vitamin d 2

Article	Year
Mechanisms of solid-state reactions of drugs. Journal of pharmaceutical sciences, 1976, Volume: 65, Issue:1 Topics: Aminosalicylic Acids; Ammonia; Anhydrides; Arsenicals; Aspirin; Chemistry, Pharmaceutical; Cinnamates; Coloring Agents; Crystallization; Cyclization; Decarboxylation; Drug Stability; Ergocalciferols; Fatty Acids, Unsaturated; Hot Temperature; Hydrolysis; Isomerism; Nucleic Acids; Pharmaceutical Preparations; Photochemistry; Polyenes; Vitamin A	1976

Article

Year

Mechanisms of solid-state reactions of drugs.

Journal of pharmaceutical sciences, 1976, Volume: 65, Issue:1

Topics: Aminosalicylic Acids; Ammonia; Anhydrides; Arsenicals; Aspirin; Chemistry, Pharmaceutical; Cinnamates; Coloring Agents; Crystallization; Cyclization; Decarboxylation; Drug Stability; Ergocalciferols; Fatty Acids, Unsaturated; Hot Temperature; Hydrolysis; Isomerism; Nucleic Acids; Pharmaceutical Preparations; Photochemistry; Polyenes; Vitamin A

1976

Other Studies

1 other study(ies) available for arsenic and vitamin d 2

Article	Year
19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. Cancer research, 2005, Mar-15, Volume: 65, Issue:6 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Screening Assays, Antitumor; Drug Synergism; Ergocalciferols; Gene Expression; HL-60 Cells; Humans; Leukemia, Myeloid; Mitochondria; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Steroid Hydroxylases; Vitamin D3 24-Hydroxylase	2005

Article

Year

19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.

Cancer research, 2005, Mar-15, Volume: 65, Issue:6

Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Screening Assays, Antitumor; Drug Synergism; Ergocalciferols; Gene Expression; HL-60 Cells; Humans; Leukemia, Myeloid; Mitochondria; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Steroid Hydroxylases; Vitamin D3 24-Hydroxylase

2005